USE OF INHIBITORS OF THE ACTIVITY OR FUNCTION OF PI3K FOR THE TREATMENT OF PRIMARY SJOGREN'S SYNDROME

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

BIETH, BRUNO,BURKHART, CHRISTOPH,CHRIST, ANDREAS,DE BUCK, STEFAN,KALIS, CHRISTOPH,LINDGREN, SAM

申请号：

CA3011205

公开号：

CA3011205A1

申请日:

2017.02.10

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

The invention relates to the use of 1-{(S)-3-[6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)- 5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-ylamino]-pyrrolidin-1-yl}-propan-1-one or pharmaceuticallyacceptable salts thereof for the treatmentof primary Sjögren's Syndrome.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/